The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea

International Journal of Dermatology

Volumn 46, Issue 10, 2007, Pages 1087-1091

  Harari, Marco ^a,b,c,d   Novack, Lena ^a,b,c,d   Barth, Joachim ^a,b,c,d   David, Michael ^a,b,c,d   Friger, Michael ^a,b,c,d   Moses, Shimon W ^a,b,c,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b DMZ MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d Dermatological Practice ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLIMATOTHERAPY; DISEASE DURATION; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; RECURRENT DISEASE; REMISSION; SEA; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; CLIMATOTHERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSORIASIS; QUALITY OF LIFE; RADIATION DOSAGE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 34848913238     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03278.x     Document Type: Article

References (18)

1. Harari M, Shani J. Demographic evaluation of successful antipsoriatic climatotherapy at the Dead Sea (Israel) DMZ Clinic. Int J Dermatol 1997; 36: 304-308.
2. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51-59.
3. Carlin CD, Feldman SR, Krueger JG, et al. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol 2004; 50: 859-866.
4. Gordon KB, Feldman SR, Koo JYM, et al. Definitions of measures of effect of duration for psoriasis treatments. Arch Dermatol 2005; 141: 82-84.
5. Kudish AI, Abels DJ, Harari M. Ultraviolet radiation properties as applied to photoclimatherapy at the Dead Sea. Int J Dermatol 2003; 42: 359-365.
6. Ashcroft DM, Li Wan Po A, Griffiths CE. Therapeutic strategies for psoriasis. J Clin Pharm Ther 2005; 25: 1-10.
7. Karrer S, Eholzer C, Ackermann G, et al. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. Dermatology 2001; 202: 108-115.
8. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E, et al. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 1999; 141: 497-501.
9. Krueger GG, Ellis CN. Alefacept therapy produces remission for patients with chronic plaque psoriasis. Br J Dermatol 2003; 148: 784-788.
10. Langley RG, Gordon KB. Biologic agents for chronic plaque psoriasis: duration of response. Poster presented at American Academy of Dermatology, 63 rd Annual Meeting, February 18-22, 2005, New Orleans, LA.
11. Hodak E, Gottlieb AB, Segal T, et al. Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation. J Am Acad Dermatol 2003; 49: 451-457.
12. Abels DJ, Harari M. Psoriasis remission time at the Dead Sea. J Am Acad Dermatol 2000; 43: 325-326.
13. Blick U, Angster H. Katamnestische Untersuchungen zur Behandlung der Psoriasis am Toten Meer. Prävention und Rehabilitation 1992; 4: 37-41.
14. Swiss comparative study on psoriasis at the Dead Sea. Data on file.
15. Weisman S, Pollack CR, Gottschalk RW. Psoriasis disease severity measures: Comparing efficacy of treatments for severe psoriasis. J Dermatol Treat 2003; 14: 158-165.
16. Shani J, Seidl V, Hristakieva E, et al. Indications, contraindications and possible side-effects of climatotherapy at the Dead Sea. Int J Dermatol 1997; 36: 481-492.
17. Kuschelevsky AP, Harari M, Kudish AI, et al. Safety of solar phototherapy at the Dead Sea. J Am Acad Dermatol 1998; 38: 447-452.
18. David M, Tsukrov B, Adler B, et al. Actinic damage among patients with psoriasis treated by climatotherapy at the Dead Sea. J Am Acad Dermatol 2005; 52: 445-450.